Health ❯Healthcare ❯Immunology

Vaccine Efficacy

Variant Strains Protein-based Vaccines Cross-Protection Clinical Trials Antibody Response Influenza Vaccines Antibody Production

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

The company plans to resubmit its application later this year following interim results from its Phase 3 flu vaccine trial, expected this summer.

FDA Authorizes New Novavax Vaccine Targeting Omicron Variant